Researcher
Patrik Verstreken
- Disciplines (Flanders Institute for Biotechnology):Analysis of next-generation sequence data, Cell death, Behavioural neuroscience
- Disciplines (KU Leuven):Neurological and neuromuscular diseases
- See also: Patrik Verstreken (Flanders Institute for Biotechnology)
Affiliations
- Research Group Molecular Neurobiology (VIB-KU Leuven) (Division)
Responsible
From1 Jan 2017 → Today - Laboratory of Neuronal Communication (VIB-KU Leuven) (Lab)
Responsible
From1 Jan 2008 → Today - Laboratory of Neuronal Communication (VIB-KU Leuven) (Lab)
Member
From1 Jan 2017 → Today - VIB-KU Leuven Center for Brain & Disease Research (Research Center)
Responsible
From1 Jan 2017 → Today - Verstreken Lab (Research group)
Responsible
From1 Jan 2017 → Today - Department of Human Genetics (Department)
Member
From1 Apr 2009 → 31 Dec 2016
Projects
1 - 10 of 54
- The Role of Parkinsonism genes in synaptic autophagyFrom1 Jan 2024 → TodayFunding: FWO research project (including WEAVE projects)
- Tau-dependent synaptic remodeling in health and diseaseFrom1 Jan 2024 → TodayFunding: FWO research project (including WEAVE projects)
- Translational Markers for Precision Medicine in Modifying Parkinson's DiseaseFrom1 Feb 2023 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Investigating cell type specific defects in protein quality control across the genetic landscape of Parkinson’s diseaseFrom1 Oct 2022 → TodayFunding: FWO junior postdoctoral fellowship
- When size matters: a platform to study molecular interactions and multimerisationFrom1 May 2022 → TodayFunding: FWO Medium Size Research Infrastructure
- Dissecting the genetic interactions controlling α-Synuclein accumulation in Parkinson’s DiseaseFrom15 Mar 2022 → TodayFunding: FWO fellowships
- Analyzing the regulation of synaptic vesicle mobility by pre-synaptic liquid phase-separation in health and diseaseFrom7 Mar 2022 → TodayFunding: FWO fellowships
- Therapeutic targeting of pathogenic presynaptic Tau in human neurons in a chimeric Alzheimer’s Disease mouse modelFrom24 Jan 2022 → TodayFunding: FWO Strategic Basic Research Grant
- Investigating cell type specific defects in protein quality control across the genetic landscape of Parkinson’s disease.From1 Oct 2021 → 30 Sep 2022Funding: BOF - postdoctoral mandates
- Resilience and vulnerability in the cellular phase of Alzheimer’s disease.From1 Oct 2021 → TodayFunding: BOF - Methusalem
Publications
41 - 50 of 146
- Assaying Mutants of Clathrin-Mediated Endocytosis in the Fly Eye(2018)
Authors: Elsa Lauwers, Patrik Verstreken
Pages: 109 - 119 - Imaging mitophagy in the fruit fly(2018)
Authors: Tom Cornelissen, Patrik Verstreken, Wim Vandenberghe
Pages: 1656 - 1657 - Dual loss of succinate dehydrogenase (SDH) and complex I activity is necessary to recapitulate the metabolic phenotype of SDH mutant tumors(2017)
Authors: Gianmarco Rinaldi, Ruben Boon, Kristine Metzger, Karin Voordeckers, Patrik Verstreken, David Cassiman, Pieter Vermeersch, Catherine Verfaillie, Sarah-Maria Fendt
Pages: 187 - 197 - Protein turnover at synapses: implications for parkinson's disease(2017)
Authors: Patrik Verstreken
Pages: 44 - 44 - Autophagy in the presynaptic compartment in health and disease(2017)
Authors: Vinoy Vijayan, Patrik Verstreken
Pages: 1895 - 1906 - Presynaptic protein homeostasis and neuronal function(2017)
Authors: Yu-Chun Wang, Elsa Lauwers, Patrik Verstreken
Pages: 38 - 46 - The SAC1 domain in synaptojanin is required for autophagosome maturation at presynaptic terminals(2017)
Authors: Roeland Vanhauwaert, Adekunle Bademosi, Laura Bounti, Serguei Gontcharenko, Sven Vilain, Natalia Gunko, Sandra Fausia Soukup, Patrik Verstreken
Pages: 1392 - 1411 - Tau association with synaptic vesicles causes presynaptic dysfunction(2017)
Authors: Lujia Zhou, Joseph McInnes, Matthew Holt, Yu-Chun Wang, Sven Vilain, Bart De Strooper, Joris de Wit, Patrik Verstreken
Pages: 15295 - EndoA/Endophilin-A creates docking stations for autophagic proteins at synapses(2017)
Authors: Sandra Fausia Soukup, Patrik Verstreken
Pages: 971 - 972 - Neurons eat glutamate to stay alive(2017)
Authors: Sarah-Maria Fendt, Patrik Verstreken
Pages: 863 - 865
Patents
1 - 10 of 10
- Screening method for synaptogyrin-3 inhibitors (Inventor)
- Targeting synaptogyrin-3 in tauopathy treatment (Inventor)
- Targeting synaptogyrin-3 in tauopathy treatment (Inventor)
- Means and methods for treatment of early-onset parkinson's disease (Inventor)
- Means and methods for treatment of early-onset parkinson's disease (Inventor)
- Compounds for treatment of intractable epilepsy and doors syndrome (Inventor)
- Targeting synaptogyrin-3 in tauopathy treatment (Inventor)
- Compounds for treatment of intractable epilepsy and doors syndrome (Inventor)
- Restoring phosphorylation of a novel pink1 substrate to treat parkinson's disease (Inventor)
- Restoring phosphorylation of a novel pink1 substrate to treat parkinson's disease (Inventor)